Aurora Cannabis (TSX:ACB) Dominates Exports

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is a global medical cannabis company founded in 2006. The company maintains nine popular medical cannabis brands, including Aurora, CanniMed, and MedReleaf. Exclusive foreign government supply contracts with Italy, Germany, Brazil, and Australia give Aurora a definite advantage over competitors. Aurora’s stock price has not done as well as peers such as Canopy Growth (TSX:WEED)(NYSE:CGC) and Cronos…

Read More

Alert! Are Cannabis Stocks a Bull Trap This Summer?

Back in mid-April, I’d warned investors about the cannabis sector, as we awaited the next round of earnings from several of the top producers. As expected, earnings were a mixed bag for producers like Canopy Growth (TSX:WEED)(NYSE:CGC) and Aurora Cannabis (TSX:ACB)(NYSE:ACB). Overall, recreational sales have slipped in 2019. This is jarring after the hype surrounding recreational legalization. Horizons Marijuana Life…

Read More

Why the Bruce Linton Firing Should Be a Wake-Up Call for the Industry

Bruce Linton is a household name in the cannabis industry. He became the poster boy for the industry’s growth and all the potential that it offered. He’d often be in interviews on TV discussing the goals for Canopy Growth (TSX:WEED)(NYSE:CGC) and did a great job of captivating audiences and getting people excited about the company. However, when he was let…

Read More

Cannabis Investors: 3 Reasons Why Your Profits Could Go Up in Smoke

After some very impressive moves from stocks in the sector — including Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) shares increasing 3,662% since 2014 — many marijuana investors are sitting on some sizeable gains. Most are prepared to hold on for the long-term, convinced we’ve only scratched the surface of marijuana’s potential. Remember, the drug has only been legal in Canada for less…

Read More

Should You Buy CannTrust Holdings (TSX:TRST) on Recent Rumours?

CannTrust Holdings’s (TSX:TRST)(NYSE:CTST) recent downfall has been well documented. The company was caught illegally growing marijuana in areas not approved by Health Canada. The fallout was immediate. In the days following the bombshell, CannTrust lost 60% of its value. Although it has since recouped some of that, the company is still trading at a near 50% discount to where it…

Read More

Millennials: Should You Invest in Bitcoin or Cannabis Today?

The second half of this decade has seen the emergence of two explosive asset classes that have been big draws for millennials. Bitcoin launched in January 2009 and remained something of a novelty for libertarian-minded and anti-establishment investors until a 2017 bull run changed everything. Cannabis is a different story. Its use dates to ancient times, but its entrance into…

Read More

Should You Buy Cronos Group (TSX:CRON) on the Dip?

Cronos Group (TSX:CRON)(NASDAQ:CRON) is perhaps the most expensive cannabis stock as far as forward valuations are concerned. It’s also been the target of several analyst downgrades thanks to its premium multiple to its peers. With the entire sector experiencing a pullback during the past few weeks, here are two reasons why you should buy Cronos, and one reason why you…

Read More

Canopy Growth (TSX:WEED) CEO Ousted: Is the Stock Still a Buy?

The departure of the embattled Bruce Linton from Canopy Growth (TSX:WEED)(NYSE:CGC) on July 3 seems to be hurting the largest cannabis company in the world. The company’s founder was mainly responsible for Canopy’s growth for the past six years. Today, there’s doubt as to whether investors should still buy WEED. Linton left the company with 5.6 million square feet of…

Read More